Read articles from Global

September 30, 2025 by inews.co.uk

Vaping is often claimed to be 95% safer than smoking, but there are debates on the accuracy of this statistic. Public health messaging on vaping's safety is under scrutiny, with concerns about potential misinformation leading to increased youth vaping. However, research indicates that while vaping is relatively safer, it is not risk-free. The discussion highlights the importance of transparent communication in public health messaging. Contrary to assumptions, youth perceptions on vaping harm have shifted negatively. Additionally, promoting baby-led weaning and debunking myths about excessive water consumption are other topics of interest in recent articles. Moreover, a group of psychologists is focusing on correcting errors in scientific research.

September 29, 2025 by drugtopics.com

Vaping during pregnancy poses risks such as preterm birth, low birth weight, and fetal growth issues. A study suggests complete nicotine cessation for pregnant individuals due to harmful substances in e-cigarettes. Up to 7% of women vape during pregnancy, increasing concerns despite some considering it safer than smoking. Research shows a 40% higher risk of preterm birth, 49% risk of low birth weight, and 32% risk of small-for-gestational-age babies with vaping. The study reviewed data from 9 studies involving 423,680 pregnant women. Advocates stress the need to educate on risks, support quitting, and regulate vaping marketing to protect maternal and fetal health.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 26, 2025 by aei.org

In the text, the authors highlight the advantages of transitioning smokers to safer alternatives like vapes but criticize the FDA's barriers hindering these products' market entry, leading to a thriving illicit market. They advocate for significant reforms to the FDA's authorization process, wanting to bring around 4,000 safer products to market, reduce review barriers, and promote a competitive legal market. The text discusses the state of the tobacco and nicotine market, the regulatory challenges, and offers 15 practical reform proposals to improve the system's efficiency, focusing on transparent standards, post-market surveillance, and broadening product availability.

September 26, 2025 by realclearhealth.com

Last week, officials raided an illegal vape operation near Chicago, seizing 600,000 units. Most vapes on the market are illicit, mainly smuggled from China. FDA regulations on vaping products are stringent, leading to a lack of safe alternatives and favoring cigarettes. The FDA should reform its approval process, focusing on monitoring markets and providing clear safety standards. This approach, as seen in the European Union and the UK, can streamline the process and educate consumers accurately. By prioritizing harm reduction over strict regulations, the FDA can support safer smoking alternatives and combat the illicit market.

September 26, 2025 by medscape.com

Cardiovascular disease (CVD) is a global leading cause of death. The longevity dividend has brought a "prevention debt." Hypertension is a key risk factor, with low control rates. Obesity, diabetes, and environmental factors like climate change, air pollution, and noise further increase CVD risks. Europe is implementing policies, such as the EU Cardiovascular Health Plan and clean air initiatives, to combat rising CVD rates. Tobacco and new nicotine products pose risks, with the EU taking steps towards regulation. Nutrition and lifestyle changes are crucial for prevention. Measures like the UK's soft drinks tax show promise. Overall, coordinated efforts are vital for tackling CVD effectively.

September 25, 2025 by gfn.tv

In this interview, tobacco harm reduction advocate Nancy Loucas unpacks how consumer voices are pushing back against vaping misinformation in New Zealand, why education matters in a “post-truth” world, and how Asia-Pacific communities win by doing it “their way".